Xuejun Zhu
- Dermatology top 1%
- Immunology top 5%
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 5
- Immunology and Allergy top 5%
- Biological Psychiatry top 10%
- Behavioral Neuroscience top 10%
-
- Autoimmune Bullous Skin Diseases 9
-
- Urticaria and Related Conditions 5
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- CAR-T cell therapy research 4
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (2 papers)Nature Immunology (1 paper)
- Partner nations
- ChinaUnited StatesPoland
In The Last Decade
Xuejun Zhu
48 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 100
- Dermatology 318
- Immunology 693
- Immunology and Allergy 121
- Biological Psychiatry 34
- Behavioral Neuroscience 45
Countries citing papers authored by Xuejun Zhu
This map shows the geographic impact of Xuejun Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejun Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejun Zhu more than expected).
Fields of papers citing papers by Xuejun Zhu
This network shows the impact of papers produced by Xuejun Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejun Zhu. The network helps show where Xuejun Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuejun Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 46 | |
| 4 | 2020 | 2 | |
| 5 | 2020 | 0 | |
| 6 | 2019 | 46 | |
| 7 | 2018 | 23 | |
| 8 | 2017 | 55 | |
| 9 | 2016 | 72 | |
| 10 | 2015 | 5 | |
| 11 | 2015 | 9 | |
| 12 | Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: results from a phase 3 clinical trial (LOTUS). | 2012 | 75 |
| 13 | 2011 | 6 | |
| 14 | 2010 | 4 | |
| 15 | 2009 | 4 | |
| 16 | 2009 | 12 | |
| 17 | 2004 | 316 | |
| 18 | A Multicentre,Double-blind,Randomized,Parallel Comparative Study on the Efficacy and Safety of Mizolastine versus Loratadine in the Treatment of Chronic Urticaria | 2003 | 2 |
| 19 | 2002 | 26 | |
| 20 | 1998 | 0 |
About Xuejun Zhu
Xuejun Zhu is a scholar working on Immunology, Pathology and Forensic Medicine and Dermatology, having authored 54 papers that have together received 1.6k indexed citations. Recurring topics across this work include Autoimmune Bullous Skin Diseases (9 papers), Immune Cell Function and Interaction (6 papers), Urticaria and Related Conditions (5 papers), Immunotherapy and Immune Responses (5 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Dermatology (318 citations), Immunology (693 citations) and Immunology and Allergy (121 citations). Xuejun Zhu has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Xin Huang, Xuetao Cao, Fang Tian, Minghui Zhang, Jianli Wang, Hua Tang, Wengang Song, Jun Guo, Zhenhong Guo and Huazhang An. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.